Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 1, 2012, Pages 39-45

  Bergaya, Sonia ^a,b   Vidal Petiot, Emmanuelle ^a,b   Jeunemaitre, Xavier ^a,b,c   Hadchouel, Juliette ^a,b  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

epithelial sodium channel; hypertension; Na Cl cotransporter; renal outer medullary potassium channel

Indexed keywords

PROTEIN KINASE WNK1; SODIUM CHLORIDE COTRANSPORTER; THIAZIDE DIURETIC AGENT;

AUTOSOMAL DOMINANT INHERITANCE; BLOOD PRESSURE; GENE ACTIVATION; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPERVOLEMIA; METABOLIC ACIDOSIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; PSEUDOHYPOALDOSTERONISM TYPE 2; REVIEW;

ACIDOSIS; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERKALEMIA; HYPERTENSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MUTATION; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; PSEUDOHYPOPARATHYROIDISM; SODIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM CHLORIDE SYMPORTERS;

EID: 83055180555     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32834d2fde     Document Type: Review

References (39)

1. Gordon RD, Klemm SA, Tunny TJ. et al. Gordon's syndrome: a sodiumvolume-dependent form of hypertension with a genetic basis. In: Brenner JHLaBM, editor. Hypertension: pathology, diagnosis and management, 2nd ed. Raven Press Ltd: New York; 1995. pp. 2111-2113.
2. Arroyo JP, Ronzaud C, Lagnaz D, et al. Aldosterone paradox: differential regulation of ion transport in distal nephron. Physiology (Bethesda) 2011; 26:115-123.
3. Wilson FH, Disse-Nicodeme S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293:1107-1112. (Pubitemid 32758085)
4. Xu B, English JM, Wilsbacher JL, et al. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 2000; 275:16795-16801. (Pubitemid 30398913)
5. Verissimo F, Jordan P. WNK kinases, a novel protein kinase subfamily in multicellular organisms. Oncogene 2001; 20:5562-5569. (Pubitemid 32889495)
6. Delaloy C, Lu J, Houot AM, et al. Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform. Mol Cell Biol 2003; 23:9208-9221. (Pubitemid 37499808)
7. O'Reilly M, Marshall E, Macgillivray T, et al. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol 2006; 17:2402-2413. (Pubitemid 44300956)
8. Delaloy C, Elvira-Matelot E, Clemessy M, et al. Deletion of WNK1 first intron results in misregulation of both isoforms in renal and extrarenal tissues. Hypertension 2008; 52:1149-1154.
9. Subramanya AR, Yang CL, Zhu X, Ellison DH. Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform. Am J Physiol Renal Physiol 2006; 290:F619-F624. (Pubitemid 43724963)
10. Yang CL, Zhu X, Ellison DH. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest 2007; 117:3403-3411. (Pubitemid 350096996)
11. Vargas-Poussou R, Dahan K, Kahila D, et al. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol 2011; 22:693-703.
12. Mayan H, Attar-Herzberg D, Shaharabany M, et al. Increased urinary Na-Cl cotransporter protein in familial hyperkalaemia and hypertension. Nephrol Dial Transplant 2008; 23:492-496. (Pubitemid 351767631)
13. Lalioti MD, Zhang J, Volkman HM, et al. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006; 38:1124-1132. (Pubitemid 44470357)
14. Yang SS, Morimoto T, Rai T, et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab 2007; 5:331-344. (Pubitemid 46679517)
15. Hadchouel J, Soukaseum C, Busst C, et al. Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension. Proc Natl Acad Sci USA 2010; 107:18109-18114.
16. Liu Z, Xie J, Wu T, et al. Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models. Hum Mol Genet 2011; 20:855-866.
17. Paulais M, Bloch-Faure M, Picard N, et al. Renal phenotype in mice lacking the Kir5.1 (Kcnj16) K+ channel subunit contrasts with that observed in SeSAME/EAST syndrome. Proc Natl Acad Sci USA 2011; 108:10361-10366.
18. Subramanya AR, Liu J, Ellison DH, et al. WNK4 diverts the thiazide-sensitive NaCl cotransporter to the lysosome and stimulates AP-3 interaction. J Biol Chem 2009; 284:18471-18480.
19. Zhou B, Zhuang J, Gu D, et al. WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathway. J Am Soc Nephrol 2009; 21:82-92.
20. Moriguchi T, Urushiyama S, Hisamoto N, et al. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem 2005; 280:42685-42693. (Pubitemid 43049227)
21. Richardson C, Rafiqi FH, Karlsson HK, et al. Activation of the thiazidesensitive Na+-Cl-cotransporter by the WNK-regulated kinases SPAK and OSR1. J Cell Sci 2008; 121:675-684. (Pubitemid 351524166)
22. Rafiqi FH, Zuber AM, Glover M, et al. Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol Med 2010; 2:63-75.
23. Bergaya S, Faure S, Baudrie V, et al. WNK1 regulates vasoconstriction and blood pressure response to {alpha}1-adrenergic stimulation in mice. Hypertension 2011; 3:439-445.
24. Zambrowicz BP, Abuin A, Ramirez-Solis R, et al. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci USA 2003; 100:14109-14114. (Pubitemid 37499199)
25. Xie J, Wu T, Xu K, et al. Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice. Am J Pathol 2009; 175:1315-1327.
26. Farfel Z, Mayan H, Yaacov Y, et al. WNK4 regulates airway Na+ transport: study of familial hyperkalaemia and hypertension. Eur J Clin Invest 2005; 35:410-415. (Pubitemid 40826841)
27. Ring AM, Cheng SX, Leng Q, et al. WNK4 regulates activity of the epithelial Na+ channel in vitro and in vivo. Proc Natl Acad Sci USA 2007; 104:4020-4024. (Pubitemid 47181571)
28. Xu BE, Stippec S, Chu PY, et al. WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci USA 2005; 102:10315-10320. (Pubitemid 41023368)
29. Cope G, Murthy M, Golbang AP, et al. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4. J Am Soc Nephrol 2006; 17:1867-1874. (Pubitemid 44036171)
30. Kahle KT, Wilson FH, Leng Q, et al. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nat Genet 2003; 35:372-376. (Pubitemid 37486922)
31. Lazrak A, Liu Z, Huang CL. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci USA 2006; 103:1615-1620. (Pubitemid 43191213)
32. Wade JB, Fang L, Liu J, et al. WNK1 kinase isoform switch regulates renal potassium excretion. Proc Natl Acad Sci USA 2006; 103:8558-8563. (Pubitemid 43838494)
33. Liu Z, Wang HR, Huang CL. Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase. J Biol Chem 2009; 284:12198-12206.
34. Schambelan M, Sebastian A, Rector FC Jr. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Kidney Int 1981; 19:716-727. (Pubitemid 11064677)
35. Take C, Ikeda K, Kurasawa T, Kurokawa K. Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism. N Engl J Med 1991; 324:472-476.
36. Ohta A, Yang SS, Rai T, et al. Overexpression of human WNK1 increases paracellular chloride permeability and phosphorylation of claudin-4 in MDCKII cells. Biochem Biophys Res Commun 2006; 349:804-808. (Pubitemid 44344584)
37. Delaloy C, Hadchouel J, Imbert-Teboul M, et al. Cardiovascular expression of the mouse WNK1 gene during development and adulthood revealed by a BAC reporter assay. Am J Pathol 2006; 169:105-118.
38. Yang SS, Lo YF, Wu CC, et al. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol 2010; 21:1868-1877.
39. Park HW, Kim JY, Choi SK, et al. Serine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculature. Proc Natl Acad Sci USA 2011; 108:10750-10755.